PortViewPortView
Pfizer logo

Pfizer (PFE) Stock Analysis

NYSEHealth CarePharmaceuticals

$28.96+1.44%
1-year price historyRange $23.60 – $28.97
52-week range$28.96
$23.58$29.09

What Pfizer does

Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.

Key metrics

Market cap
$165.06B
P/E (TTM)
9.50
EPS (TTM)
$3.05
Beta
0.28
Dividend yield
5.94%
Revenue / share
$11.18
50-day avg
$25.71
200-day avg
$26.11
52-week high
$29.09
52-week low
$23.58
CEO
Albert Bourla

ETFs linked to PFE

Broad-market and Health Care sector ETFs an investor holding Pfizer is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how PFE fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze PFE in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Pfizer?
Pfizer trades under the ticker PFE on NYSE.
Which exchange is PFE listed on?
PFE is listed on NYSE.
What sector does Pfizer operate in?
Pfizer is classified in the Health Care sector (Pharmaceuticals industry).
How can PortView help analyze PFE in a portfolio?
PortView shows PFE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.